TRGM Stock Overview

TRGM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($3K)

Shares are highly illiquid

Latest financial reports are more than a year old

My Notes

Capture your thoughts, links and company narrative

Targeted Medical Pharma, Inc. Competitors

Ampio Pharmaceuticals

OTCPK:AMPE

US$11.4k

Lucy Scientific Discovery

OTCPK:LSDI.F

US$176.0

Hero Technologies

OTCPK:HENC

US$563.0

BZAM

OTCPK:BZAM.F

US$2.7k

Price History & Performance

Summary of share price highs, lows and changes for Targeted Medical Pharma
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.00%
5 Year Change	-99.29%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	TRGM	US Pharmaceuticals	US Market
7D	0%	1.2%	-0.3%
1Y	n/a	1.1%	20.4%

Return vs Industry: Insufficient data to determine how TRGM performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how TRGM performed against the US Market.

Price Volatility

Is TRGM's price volatile compared to industry and market?
TRGM volatility
TRGM Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.4%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: TRGM has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine TRGM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1996	n/a	n/a	www.targetedmedicalpharma.com

Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting.

Targeted Medical Pharma, Inc. Fundamentals Summary

How do Targeted Medical Pharma's earnings and revenue compare to its market cap?
TRGM fundamental statistics
Market cap	US$2.95k
Earnings (TTM)	-US$3.04m
Revenue (TTM)	US$5.26m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is TRGM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TRGM income statement (TTM)
Revenue	US$5.26m
Cost of Revenue	US$2.10m
Gross Profit	US$3.17m
Other Expenses	US$6.21m
Earnings	-US$3.04m

Last Reported Earnings

Dec 31, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did TRGM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/24 16:19
End of Day Share Price	2023/07/27 00:00
Earnings	2015/12/31
Annual Earnings	2015/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Targeted Medical Pharma, Inc. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Dan Trang	Stonegate Capital Markets, Inc.